drugset / Trial / NCT05235191

Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies

NCT05235191

Phase 3 Completed 80 enrolled University of Sao Paulo
RandomizedParallel-groupTriple-blindTreatment

Summary

Opioids are currently ranked as third-line agents for neuropathic pain (NP) treatment. The opioids more frequently tested for NP were tramadol, oxycodone and morphine. In the present study test the safety and effectiveness of methadone in patients with NP who remain symptomatic despite the use of first and second line drugs in a placebo-controlled randomized approach.

Timeline

Start
2019-09-06
Primary completion
2023-01-20
Completion
2023-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Methadone Other / unclassified 30 mg

Indications